Sabra Healthcare REIT, Inc.

SBRA Real Estate Reit Healthcare Facilities

Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024. In the quarter to June 2026, revenue grew 24.7%, EPS fell 135.7%, free cash flow fell 666.1% and total debt rose 5.91%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three.

19.74 0.13 +0.66%
Market cap
$5.0B
P/E
76.0×
Fwd P/E
48.8×
Dividend yield
6.08%
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Sabra Healthcare REIT, Inc. (SBRA) EV/Sales

Alert me on EV/Sales

As of 30 October 2026, Sabra Healthcare REIT, Inc. (SBRA) trades at a EV/Sales of 8.6×. Over the past ten years it has ranged from 5.2× (March 2020) to 18.0× (October 2017); the current reading is higher than 10% of that period. That is in line with the Reit Healthcare Facilities industry median of 8.4× and above the Real Estate sector median of 7.3×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 9.1× (0.34%)
FY2024 9.1× 4.26%
FY2023 8.7× 1.58%
FY2022 8.6× (6.75%)
FY2021 9.2× (6.40%)
FY2020 9.8× 2.57%
FY2019 9.6× (2.15%)
FY2018 9.8× (17.03%)
FY2017 11.8× 10.58%
FY2016 10.7× (2.66%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 8.5× (6.47%)
Mar 2026 9.1× 0.31%
Dec 2025 9.1× (1.49%)
Sep 2025 9.2× (0.32%)
42 more quarters

Against its own ten years

Low 5.2× High 18.0×
Ten-year median 9.8×
Current reading's percentile 11

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on SBRA